AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.910
-0.060 (-1.51%)
At close: Jun 12, 2026, 4:00 PM EDT
3.980
+0.070 (1.79%)
After-hours: Jun 12, 2026, 6:51 PM EDT
AVITA Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 8.31 | 10.24 | 14.05 | 22.12 | 18.16 | 110.75 |
Short-Term Investments | 5.95 | 7.94 | 21.84 | 66.94 | 61.18 | - |
Cash & Short-Term Investments | 14.26 | 18.19 | 35.89 | 89.06 | 79.34 | 110.75 |
Cash Growth | -44.76% | -49.32% | -59.71% | 12.24% | -28.36% | 50.39% |
Accounts Receivable | 9.89 | 9.09 | 11.79 | 7.66 | 3.52 | 3.47 |
Other Receivables | - | - | - | 0.03 | 0.9 | 3.94 |
Total Trade Receivables | 9.89 | 9.09 | 11.79 | 7.69 | 4.41 | 7.4 |
Inventory | 6.12 | 6.93 | 7.27 | 5.6 | 2.13 | 1.65 |
Other Current Assets | 1.38 | 1.29 | 2.06 | 1.66 | 1.58 | 1.33 |
Total Current Assets | 31.65 | 35.49 | 57 | 104.01 | 87.46 | 121.33 |
Net Property, Plant & Equipment | 10.88 | 11.53 | 13.59 | 4.32 | 2.05 | 2.94 |
Other Intangible Assets | 5.44 | 5.65 | 5.57 | 0.49 | 0.47 | 0.47 |
Long-Term Investments | - | - | - | - | 6.93 | - |
Other Long-Term Assets | 3.58 | 3.73 | 3.55 | 2.83 | 1.36 | 0.96 |
Total Assets | 51.54 | 56.39 | 79.71 | 111.64 | 98.26 | 125.5 |
Accounts Payable | 7.22 | 8.96 | 6.29 | 3.79 | 3 | 3.12 |
Accrued Expenses | 7.87 | 7.81 | 10.45 | 7.97 | 6.62 | 3.32 |
Short-Term Debt | 46.14 | 42.98 | - | - | - | - |
Unearned Revenue | 0.28 | 0.29 | 0.32 | 0.36 | 0.7 | 1.08 |
Other Current Liabilities | 5.44 | 2.92 | 3.41 | 1.43 | 1.07 | 0.95 |
Total Current Liabilities | 66.67 | 62.97 | 20.48 | 13.56 | 11.39 | 8.47 |
Long-Term Debt | - | - | 42.25 | 39.81 | - | - |
Long-Term Leases | 1.98 | - | - | - | - | - |
Other Long-Term Liabilities | 5.78 | 7.94 | 9.4 | 6.82 | 1.27 | 0.5 |
Total Long-Term Liabilities | 7.76 | 7.94 | 51.65 | 46.63 | 1.27 | 0.5 |
Total Liabilities | 74.71 | 70.91 | 72.13 | 60.19 | 12.66 | 8.97 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | -0.64 | -1.29 | -1.32 | -1.13 | -0.13 | - |
Additional Paid-in Capital | 395.83 | 394.41 | 367.57 | 350.04 | 339.83 | 328.89 |
Accumulated Other Comprehensive Income | 0.65 | -1.37 | -1.94 | -1.89 | 7.63 | 8.26 |
Retained Earnings | -419.01 | - | - | - | - | - |
Total Common Shareholders' Equity | -23.17 | 391.75 | 364.31 | 347.03 | 347.33 | 337.15 |
Minority Interest | - | - | 0.24 | 0.69 | 0.56 | - |
Shareholders' Equity | -23.17 | 391.75 | 364.56 | 347.72 | 347.89 | 337.15 |
Total Liabilities & Equity | 51.54 | 56.39 | 79.71 | 111.64 | 98.26 | 125.5 |
Total Debt | 48.12 | 42.98 | 42.25 | 39.81 | 0 | 0 |
Net Cash (Debt) | -33.86 | -24.8 | -6.36 | 49.25 | 79.34 | 110.75 |
Net Cash Growth | - | - | - | -37.93% | -28.36% | 50.39% |
Net Cash Per Share | -23.41 | -17.80 | -4.91 | 38.88 | 63.47 | 97.68 |
Book Value | -23.17 | 391.75 | 364.31 | 347.03 | 347.33 | 337.15 |
Book Value Per Share | -16.02 | 281.22 | 281.51 | 273.99 | 277.86 | 297.39 |
Tangible Book Value | -28.61 | 386.11 | 358.74 | 346.54 | 346.86 | 336.68 |
Tangible Book Value Per Share | -19.78 | 277.17 | 277.20 | 273.61 | 277.49 | 296.97 |